Free Newsletter
Genentech chooses Google for Outlook
Genentech says it sees Google as a strategic IT platform, reports ChannelWeb. The big biopharma moved its 15,000 employees to Google Apps last year, despite seeing user preference for Outlook as hurdle. Genentech credits Google's MAPI-based synchronizer for overcoming earlier performance issues compared with Microsoft Exchange. Article
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
